Takeda’s dengue vaccine has met its target of protection against the disease in children – but there are already concerns about mixed results among different strains of the potentially dead
Takeda is to sell off a portfolio of over-the-counter and prescription drugs in the Near East, Middle East, and Africa for $200 million to Acino, as the Japanese company aims to pay off bil
LA-based biotech ImaginAb has signed a multi-party agreement with pharma giants AstraZeneca, Pfizer, and Takeda, for technology that allows scientists to see inside tumours, and monitor whe
